Synovial Sarcoma Treatment Market Size to Reach USD 1,144.84 Mn by 2033 [Yahoo! Finance]
C4 Therapeutics, Inc. (CCCC)
NASDAQ:AMEX Investor Relations:
ir.chinacache.com
Company Research
Source: Yahoo! Finance
Ottawa, March 21, 2024 (GLOBE NEWSWIRE) -- The global synovial sarcoma treatment market size is calculated at USD 833.03 million for 2024 and is projected to surpass around USD 1,083.62 million by 2032, a study published by Towards Healthcare a sister firm of Precedence Research. Insight Highlights: Surgery remains the dominant treatment approach, capturing a significant 56% market share in 2023. Surgery treatment dominated the market with a 56% market share in 2023. North America holds the largest market share, accounting for 41% in 2023. According to the National Institute of Health, synovial sarcoma, a type of mesenchymal tumor commonly diagnosed in individuals under the age of 30, requires appropriate treatment for management. As the occurrence of synovial sarcoma rises, there is an increasing demand for innovative therapies to address this medical need. Synovial sarcoma is a type of cancer that typically affects young adults and teenagers. It starts in the soft tissu
Show less
Read more
Impact Snapshot
Event Time:
CCCC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CCCC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CCCC alerts
High impacting C4 Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CCCC
News
- C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology ForumGlobeNewswire
- C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024 [Yahoo! FinaYahoo! Fina
- C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024GlobeNewswire
- Here's Why Meridian Small Cap Growth Fund Trimmed C4 Therapeutics (CCCC) [Yahoo! Finance]Yahoo! Finance
- C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC™ Degraders at the American Association for Cancer Research Annual Meeting 2024 [Yahoo! Finance]Yahoo! Finance
CCCC
Earnings
- 11/1/23 - Beat
CCCC
Sec Filings
- 4/10/24 - Form 4
- 4/10/24 - Form SC
- 4/2/24 - Form 4
- CCCC's page on the SEC website